Skip to content
Wenlo
Sign in
← Markets

BioMarin Pharmaceutical Inc.

Gregory R Friberg (EVP, Chief R&D Officer) reports BMRN insider transactions

4BMRNFiled Oct 1, 2026, 12:23 PM ET· Period Sep 30, 2026

About this filing

BioMarin Pharmaceutical Inc. (BMRN) filed Form 4 (insider transaction) with the SEC on Oct 1, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Gregory R Friberg · EVP, Chief R&D Officer
DateTransactionSharesPriceValueHeld afterOwnership
Sep 30, 2026F · tax withholding−4,086$60.00$245,160.0047,732Direct

More BMRN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.